Answers are grounded in this paper and cite their sources.
BACKGROUND: As more women elect to delay childbearing, the incidence of breast cancer diagnosed during pregnancy is expected to increase, thus increasing the relevance of this issue within oncology nursing. Existing literature does not sufficiently address the quality of life (QOL) of breast cancer survivors who received chemotherapy during pregnancy. OBJECTIVE: The purpose of this descriptive correlational study was to examine the psychosocial factors associated with QOL among breast cancer survivors who were pregnant while receiving chemotherapy, focusing on anxiety, depression, fear of cancer recurrence (FCR), and social support. METHODS: Validated instruments were used to assess FCR, anxiety and depression, social support, and QOL among breast cancer survivors who were pregnant during treatment. Spearman's rho correlations examined associations among psychosocial variables and QOL. Multiple regression identified factors uniquely associated with QOL after accounting for shared variance. RESULTS: QOL was significantly negatively associated with anxiety, depression, and FCR and positively associated with social support following false discovery rate adjustment. The regression model significantly predicted QOL (R2 = 0.684, P < .001). Depression and FCR remained significant independent predictors, while anxiety and social support were not significant when other variables were controlled. CONCLUSIONS: Psychological distress, particularly depressive symptoms and FCR, plays a central role in QOL among survivors who were pregnant during chemotherapy. IMPLICATIONS FOR ONCOLOGY NURSING PRACTICE: The findings underscore the need for routine psychosocial assessment to identify distress within this population. Targeted interventions may support reduced symptom burden and improved QOL.
No takes yet. Share an insight, caveat, or question.
Martínez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: